Russell Investments Group, Ltd. Jounce Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$2.8 - $7.67 $5,647 - $15,470	-2,017 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$6.58 - $10.66 $222,463 - $360,403	-33,809 Reduced 94.37%	2,017 $13,000
Q1 2021 May 10, 2021	SELL	$6.73 - $13.87 $245,725 - $506,421	-36,512 Reduced 50.47%	35,826 $367,000
Q4 2020 Feb 08, 2021	SELL	$6.37 - $10.33 $737,595 - $1.2 Million	-115,792 Reduced 61.55%	72,338 $504,000
Q3 2020 Nov 09, 2020	SELL	$4.58 - $10.95 $104,401 - $249,605	-22,795 Reduced 10.81%	188,130 $1.54 Million
Q2 2020 Aug 05, 2020	SELL	$4.17 - $7.58 $79,955 - $145,338	-19,174 Reduced 8.33%	210,925 $1.46 Million
Q1 2020 May 06, 2020	BUY	$2.91 - $8.7 $430,080 - $1.29 Million	147,794 Added 179.57%	230,099 $1.1 Million
Q4 2019 Jan 29, 2020	BUY	$2.81 - $9.21 $136,200 - $446,408	48,470 Added 143.25%	82,305 $698,000
Q3 2019 Nov 01, 2019	BUY	$3.33 - $4.93 $112,670 - $166,806	33,835 New	33,835 $113,000
Q4 2018 Feb 11, 2019	SELL	$2.69 - $6.71 $224,555 - $560,137	-83,478 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	$6.5 - $8.37 $412,828 - $531,595	63,512 Added 318.1%	83,478 $543,000
Q1 2018 May 11, 2018	SELL	$13.4 - $28.4 $164,257 - $348,127	-12,258 Reduced 38.04%	19,966 $446,000
Q3 2017 Nov 07, 2017	BUY	$11.17 - $16.99 $359,942 - $547,485	32,224	32,224 $502,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.